Abcam Ltd.

In News

Abcam joins the Innovative Health Initiative (IHI) LIGAND-AI project to advance artificial intelligence (AI)-driven drug discovery through open science, a new public-private partnership with a budget of more than €60 million. - Abcam

Abcam - Jan 20, 2026

Beta-amyloid pathway - Abcam

Abcam - Jul 30, 2025

Expedeon AG signs EUR 120 million deal with Abcam for the sale of its immunology and proteomics business - BioSpace

BioSpace - Nov 11, 2019

Danaher Wins Race to Acquire UK’s Abcam With $24 a Share Deal - Bloomberg.com

Bloomberg.com - Aug 28, 2023

Life sciences group Abcam rejects founder’s accusations over $5.7bn deal with Danaher - Financial Times

Financial Times - Oct 05, 2023

Abcam to Acquire BioVision for $340 million - GlobeNewswire

GlobeNewswire - Aug 02, 2021

Danaher to acquire Abcam in $5.7bn transaction - Financier Worldwide

Financier Worldwide - Oct 10, 2023

Abcam licenses novel Ceefourin inhibitors of multidrug resistance protein 4 from Australia’s Children’s Cancer Institute - drugtargetreview.com

drugtargetreview.com - Sep 22, 2014

Scale up, speed up: How our immunoassays can accelerate your throughput - Abcam

Abcam - Oct 09, 2024

Interleukin-8 quantification using ELISA - News-Medical

News-Medical - Sep 24, 2025

Hydrogen inhalation attenuated bleomycin-induced pulmonary fibrosis by inhibiting transforming growth factor-β1 and relevant oxidative stress and epithelial-to-mesenchymal transition - Wiley

Wiley - Sep 18, 2019

Abcam CatchPoint SimpleStep ELISA kits - Lab + Life Scientist

Lab + Life Scientist - Nov 01, 2018

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment